| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Benzoyltropein; Benzoyltropein | CFN00212 | 19145-60-9 | C15H19NO2 = 245.32 | 5mg | QQ客服：2056216494 |
| 辣根碱; Cochlearine | CFN00213 | 52418-07-2 | C15H19NO3 = 261.32 | 5mg | QQ客服：1413575084 |
| 白曼陀罗碱; Datumetine | CFN00214 | 67078-20-0 | C16H21NO3 = 275.35 | 5mg | QQ客服：215959384 |
| Tropanyl trans-cinnamate; Tropanyl trans-cinnamate | CFN00215 | 35721-92-7 | C17H21NO2 = 271.36 | 5mg | QQ客服：2159513211 |
| Tropanyl 3-hydroxy-4-methoxycinnamate; Tropanyl 3-hydroxy-4-methoxycinnamate | CFN00216 | 86702-58-1 | C18H23NO4 = 317.38 | 5mg | QQ客服：2159513211 |
| β-托品醇; Pseudotropine | CFN00217 | 135-97-7 | C8H15NO = 141.21 | 20mg | QQ客服：3257982914 |
| 3-乙酰莨菪烷; 3-Acetoxytropane | CFN00218 | 3423-26-5 | C10H17NO2 = 183.25 | 5mg | QQ客服：1413575084 |
| 妥帕可卡因; Tropacocaine | CFN00219 | 537-26-8 | C15H19NO2 = 245.32 | 5mg | QQ客服：1413575084 |
| 托品酮; Tropinone | CFN00220 | 532-24-1 | C8H13NO = 139.19 | 20mg | QQ客服：1457312923 |
| Physoperuvine; Physoperuvine | CFN00221 | 60723-27-5 | C8H15NO = 141.21 | 5mg | QQ客服：1457312923 |
| Schizanthine A; Schizanthine A | CFN00222 | 70474-24-7 | C20H29NO6 = 379.45 | 5mg | QQ客服：2159513211 |
| Schizanthine E; Schizanthine E | CFN00223 | 109031-04-1 | C26H38N2O7 = 490.59 | 5mg | QQ客服：3257982914 |
| Schizanthine G; Schizanthine G | CFN00224 | 119736-74-2 | C19H27NO6 = 365.42 | 5mg | QQ客服：3257982914 |
| Schizanthine M; Schizanthine M | CFN00225 | 119736-78-6 | C20H29NO6 = 379.45 | 5mg | QQ客服：2159513211 |
| 东莨菪醇; Scopine | CFN00226 | 498-45-3 | C8H13NO2 = 155.20 | 20mg | QQ客服：1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)